Investing.com - Intracellular Th reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Intracellular Th announced earnings per share of $-0.57 on revenue of $71.9M. Analysts polled by Investing.com EPS of $-0.81 on revenue of $65.88M.
Intracellular Th 's are down 26.01% and is trading at $50.81 , still down 23.02% from its 52 week high of $66.00 set on Thursday, April 7, 2022.
Intracellular Th shares gained 10.88% to trade at $50.81 in intra-day trade the report.
Intracellular Th follows other major Healthcare sector earnings this month
Intracellular Th's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.9B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar